Table 1.
Characteristic | No. of patients (%) |
---|---|
Sex | |
Female | 2 (6) |
Male | 29 (94) |
| |
Age | |
Median (range) | 57 (44–78) |
| |
T stage (T) | |
T1 | 1 (3) |
T2 | 14 (45) |
T3 | 8 (26) |
T4 | 8 (26) |
| |
Nodal stage (N) | |
N0 | 1 (3) |
N1 | 3 (10) |
N2a | 2 (6) |
N2b | 13 (42) |
N2c | 12 (39) |
N3 | 0 (0) |
| |
AJCC stage | |
III | 4 (13) |
IVa | 27 (87) |
| |
Smoking History at Diagnosis | |
Never smoker | 15 (48) |
Current smoker | 16 (52) |
| |
Disease sub-site | |
Tonsil | 16 (52) |
Base of tongue | 15 (48) |
| |
Total Radiation Dose | 70 Gy |
| |
No. of Fractions Received | 33 |
| |
Radiation technique | |
IMRT | 16 (52) |
IMPT | 15 (48) |
| |
Chemotherapy | |
Cetuximab | 5 (16) |
Carboplatin | 1 (3) |
Cisplatin | 24 (78) |
Docetaxel | 1 (3) |
Note.—IMPT = intensity-modulated proton therapy, IMRT = intensity-modulated photon therapy.